The present invention provides methods for modulating the level or activity of cyclin D by inhibiting EGLN2 expression or activity. The methods are particularly useful for treating or preventing a disorder associated with elevated cyclin D levels or activity, such as cancer.
申请公布号
WO2009102469(A3)
申请公布日期
2009.11.26
申请号
WO2009US00920
申请日期
2009.02.12
申请人
DANA FARBER CANCER INSTITUTE, INC.;KAELIN, WILLIAM, G.;BOMMI-REDDY, ARCHANA;GU, JINMING
